Cargando…
Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
BACKGROUND: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of...
Autores principales: | Bullock, Alex N., Russo, Santina, Amos, Ann, Pagano, Nicholas, Bregman, Howard, Debreczeni, Judit É., Lee, Wen Hwa, von Delft, Frank, Meggers, Eric, Knapp, Stefan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743286/ https://www.ncbi.nlm.nih.gov/pubmed/19841674 http://dx.doi.org/10.1371/journal.pone.0007112 |
Ejemplares similares
-
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family
por: Nonga, Olivier E., et al.
Publicado: (2021) -
Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
por: Bullock, Alex N., et al.
Publicado: (2009) -
PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016) -
High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes
por: Shakil, Md. Salman, et al.
Publicado: (2021) -
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
por: Azmanova, Maria, et al.
Publicado: (2022)